PropertyValue
?:definition
  • A recombinant, replication-deficient coronavirus vaccine composed of a genetically engineered adenovirus type 5 (Ad5) vector that expresses full-length SARS-CoV-2 spike protein (SP), with potential immunomodulating and anti-COVID-19 activities. Upon intramuscular administration of the Ad5-nCoV vaccine, the Ad5 infects human cells, which produce the SARS-CoV-2 SP, and travel to the lymph nodes where the immune system creates anti-SARS-CoV-2 SP antibodies. The antibodies recognize the SP and kill SARS-CoV-2. This prevents SARS-CoV-2 infection. SP, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C5419987_NCI>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C5419987_NCI>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all